The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•12 February 2026•

1 min read

Select Medical (SEM) Prepares for Q4 2025 Earnings Release Amidst Analyst Forecasts

A man in a suit over a stock chart with 'Mondelez International' text, surrounded by chocolate, cocoa beans, factories, and shops.

Select Medical (SEM) is scheduled to release its fourth-quarter 2025 earnings on Thursday, February 19th. Analysts anticipate the company will report earnings of $0.23 per share and revenues reaching $1.364 billion for the period. The company currently holds a 'Moderate Buy' consensus rating from analysts, with a target price of $17.80. Notably, institutional investors maintain a significant stake, owning approximately 89.48% of the company's stock. This upcoming report will be crucial for investors to assess SEM's financial health against market expectations.

Sources: